Ironshore Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for IRONSHORE PHARMS, and what generic alternatives to IRONSHORE PHARMS drugs are available?
IRONSHORE PHARMS has one approved drug.
There are fifteen US patents protecting IRONSHORE PHARMS drugs.
There are twenty-eight patent family members on IRONSHORE PHARMS drugs in fourteen countries.
Summary for Ironshore Pharms
| International Patents: | 28 |
| US Patents: | 15 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Ironshore Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ironshore Pharms | JORNAY PM | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 209311-005 | Aug 8, 2018 | RX | Yes | Yes | 9,034,902 | See Plans and Pricing | See Plans and Pricing | ||||
| Ironshore Pharms | JORNAY PM | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 209311-004 | Aug 8, 2018 | RX | Yes | No | 9,603,809 | See Plans and Pricing | See Plans and Pricing | ||||
| Ironshore Pharms | JORNAY PM | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 209311-002 | Aug 8, 2018 | RX | Yes | No | 9,028,868 | See Plans and Pricing | See Plans and Pricing | ||||
| Ironshore Pharms | JORNAY PM | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 209311-005 | Aug 8, 2018 | RX | Yes | Yes | 9,283,214 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Ironshore Pharms | JORNAY PM | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 209311-003 | Aug 8, 2018 | RX | Yes | No | 8,927,010 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Ironshore Pharms | JORNAY PM | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 209311-002 | Aug 8, 2018 | RX | Yes | No | 8,916,588 | See Plans and Pricing | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Ironshore Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2017128614 | See Plans and Pricing |
| World Intellectual Property Organization (WIPO) | 2012129551 | See Plans and Pricing |
| Japan | 6043785 | See Plans and Pricing |
| China | 110151731 | See Plans and Pricing |
| Portugal | 2688557 | See Plans and Pricing |
| South Korea | 20160135373 | See Plans and Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
